$16.51
In chiusura: Oct 9, 4:00 PM EDT
$18.87
2.3614.29%
Pre-mercato: Oct 9, 4:00 PM EDT
Lyell Immunopharma segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Analizza lo storico degli utili di Lyell Immunopharma utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
LYEL | Lyell Immunopharma | -$2.80 | -$2.71 | — | — | $34.00K | — | — | — | 11/06/2025 | |
LYEL | Lyell Immunopharma | -$3.59 | -$2.90 | -$2.89 | 0.34% | $13.00K | — | $8.00K | — | 08/12/2025 | |
LYEL | Lyell Immunopharma | -$4.80 | -$3.60 | -$3.60 | 0.00% | $3.00K | — | $7.00K | — | 05/13/2025 | |
LYEL | Lyell Immunopharma | -$3.40 | -$2.60 | -$3.20 | -23.08% | $13.00K | — | $11.00K | — | 03/11/2025 | |
LYEL | Lyell Immunopharma | -$3.40 | -$4.00 | -$2.80 | 30.00% | $25.00K | — | $34.00K | — | 11/07/2024 | |
LYEL | Lyell Immunopharma | -$0.80 | -$4.00 | -$3.00 | 25.00% | $27.00K | — | $13.00K | — | 08/07/2024 | |
LYEL | Lyell Immunopharma | -$3.60 | -$4.20 | -$3.00 | 28.57% | $65.00K | — | $3.00K | — | 05/06/2024 | |
LYEL | Lyell Immunopharma | $0.00 | -$4.60 | -$3.40 | 26.09% | $48.39M | — | $13.00K | — | 02/28/2024 | |
LYEL | Lyell Immunopharma | -$3.60 | -$5.00 | -$3.40 | 32.00% | $3.00K | — | $25.00K | — | 11/07/2023 | |
LYEL | Lyell Immunopharma | -$0.80 | -$4.60 | -$0.80 | 82.61% | $35.74M | — | $27.00K | — | 08/08/2023 | |
LYEL | Lyell Immunopharma | -$4.00 | — | -$3.60 | — | $553.00K | — | $65.00K | — | 05/04/2023 | |
LYEL | Lyell Immunopharma | -$3.40 | — | $0.00 | — | $2.82M | — | $48.39M | — | 02/28/2023 | |
LYEL | Lyell Immunopharma | -$3.00 | — | -$3.60 | — | $2.75M | — | $3.00K | — | 11/08/2022 | |
LYEL | Lyell Immunopharma | -$17.80 | — | -$0.80 | — | $2.63M | — | $35.74M | — | 08/04/2022 | |
LYEL | Lyell Immunopharma | — | — | -$4.00 | — | $2.44M | — | $553.00K | — | 05/10/2022 | |
LYEL | Lyell Immunopharma | — | — | -$3.40 | — | — | — | $2.82M | — | 03/29/2022 | |
LYEL | Lyell Immunopharma | -$35.60 | -$5.40 | -$3.00 | 44.44% | $1.07M | $2.30M | $2.75M | 19.78% | 11/12/2021 | |
LYEL | Lyell Immunopharma | -$150.80 | — | -$17.80 | — | $3.12M | — | $2.63M | — | 08/12/2021 |
Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
---|---|---|---|---|
Q2 | 2025-08-12 | $-2.89 | $-2.90 | 0.34 % |
Q1 | 2025-05-13 | $-3.60 | $-3.60 | 0.00 % |
Q4 | 2025-03-11 | $-3.20 | $-2.60 | -23.1 % |
Q3 | 2024-11-07 | $-2.80 | $-4.00 | 30.0 % |
Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
---|---|---|---|---|
Q3 | 2021-11-12 | $2.76M | $2.30M | 19.8 % |
Si prevede che Lyell Immunopharma (LYEL) fornisca risultati il novembre 6, 2025. Gli ultimi risultati sono stati pubblicati il agosto 12, 2025 per il Q2.
L'EPS effettivo era $-2.89, che superato la stima di $-2.90.
Le entrate effettive sono state $8K, che superato la stima di $0K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.